Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Feb;28(2):344–349. doi: 10.1128/jcm.28.2.344-349.1990

Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

H Mejia-López 1, O Vaca-García 1, J M Cristerna-Aguirre 1, A Cruz-Chávez 1, M Selman-Lama 1, M L Taylor 1
PMCID: PMC269604  PMID: 2312677

Abstract

Peripheral blood mononuclear cells from 20 purified protein derivative (PPD)-reactive (PPD+) tuberculous patients were cultured in autologous, tuberculous anergic, or normal serum. After 12 h of incubation, the serum was eliminated and lymphocyte transformation with PPD was performed. Transformation was inhibited only in cells incubated with anergic serum. In contrast, cells from 11 anergic tuberculous (PPD-) individuals recovered the ability to respond to an optimal PPD dose after treatment with high PPD concentrations followed by several washings. The cells which recovered returned to their initial anergic state when incubated with sera from anergic patients. Under both conditions, incubation with sera did not abolish the response to the mitogen phytohemagglutinin. Cells from healthy PPD+ or PPD- individuals were used as controls. The most important finding derived from serum analysis was the increased levels of specific immunoglobulins G and A in anergic patients.

Full text

PDF
344

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballas Z. K., Feldbush T. L., Needleman B. W., Weiler J. M. Complement inhibits immune responses: C3 preparations inhibit the generation of human cytotoxic T lymphocytes. Eur J Immunol. 1983 Apr;13(4):279–284. doi: 10.1002/eji.1830130403. [DOI] [PubMed] [Google Scholar]
  2. Bhatnagar R., Malaviya A. N., Narayanan S., Rajgopalan P., Kumar R., Bharadwaj O. P. Spectrum of immune response abnormalities in different clinical forms of tuberculosis. Am Rev Respir Dis. 1977 Feb;115(2):207–212. doi: 10.1164/arrd.1977.115.2.207. [DOI] [PubMed] [Google Scholar]
  3. Bjune G., Barnetson R. S., Ridley D. S., Kronvall G. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol. 1976 Jul;25(1):85–94. [PMC free article] [PubMed] [Google Scholar]
  4. Bullock W. E., Jr, Fasal P. Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol. 1971 Apr;106(4):888–899. [PubMed] [Google Scholar]
  5. Colizzi V., Giuntini M., Garzelli C., Campa M., Falcone G. Auto-anti-idiotypic antibodies inhibit T-cell-mediated hypersensitivity in BCG-infected mice. Cell Immunol. 1983 Aug;80(1):205–210. doi: 10.1016/0008-8749(83)90107-7. [DOI] [PubMed] [Google Scholar]
  6. Collins F. M. The immunology of tuberculosis. Am Rev Respir Dis. 1982 Mar;125(3 Pt 2):42–49. doi: 10.1164/arrd.1982.125.3P2.42. [DOI] [PubMed] [Google Scholar]
  7. Dannenberg A. M., Jr Pathogenesis of pulmonary tuberculosis. Am Rev Respir Dis. 1982 Mar;125(3 Pt 2):25–29. doi: 10.1164/arrd.1982.125.3P2.25. [DOI] [PubMed] [Google Scholar]
  8. Gatner E. M., Anderson R. Immune responses and immunostimulation in tuberculosis therapy. S Afr Med J. 1982 May 8;61(19):707–710. [PubMed] [Google Scholar]
  9. Haneberg B., Wesenberg F., Aarskog D. Lymphocyte multiplication in vitro induced by mitogens and antigens. Scand J Immunol. 1978;8(1):9–13. doi: 10.1111/j.1365-3083.1978.tb00490.x. [DOI] [PubMed] [Google Scholar]
  10. Heilman D. H., McFarland W. Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors. Int Arch Allergy Appl Immunol. 1966;30(1):58–66. doi: 10.1159/000229793. [DOI] [PubMed] [Google Scholar]
  11. Hussein Y. M., Kerr M. A., Beck J. S. The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Immunology. 1987 Jun;61(2):125–129. [PMC free article] [PubMed] [Google Scholar]
  12. Kerr M. A., Hussein Y. M., Potts R. C., Beck J. S., Sheriff M. M. Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Immunology. 1987 Jun;61(2):117–123. [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Lenzini L., Rottoli P., Rottoli L. The spectrum of human tuberculosis. Clin Exp Immunol. 1977 Feb;27(2):230–237. [PMC free article] [PubMed] [Google Scholar]
  15. McMurray D. N., Echeverri A. Cell-mediated immunity in anergic patients with pulmonary tuberculosis. Am Rev Respir Dis. 1978 Nov;118(5):827–834. doi: 10.1164/arrd.1978.118.5.827. [DOI] [PubMed] [Google Scholar]
  16. Nath I., Curtis J., Sharma A. K., Talwar G. P. Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load. Clin Exp Immunol. 1977 Sep;29(3):393–400. [PMC free article] [PubMed] [Google Scholar]
  17. Navalkar R. G. Immunology of leprosy. Crit Rev Microbiol. 1980;8(1):25–47. doi: 10.3109/10408418009085077. [DOI] [PubMed] [Google Scholar]
  18. Nelson D. S. Mouse serum factor depressing lymphocyte transformation. Experientia. 1972 Oct 15;28(10):1227–1228. doi: 10.1007/BF01946187. [DOI] [PubMed] [Google Scholar]
  19. Nelson D. S., Penrose J. M., Waters M. F., Pearson J. M., Nelson M. Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment. Clin Exp Immunol. 1975 Dec;22(3):385–392. [PMC free article] [PubMed] [Google Scholar]
  20. Newberry W. M., Jr, Chandler J. W., Jr, Chin T. D., Kirkpatrick C. H. Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol. 1968 Feb;100(2):436–443. [PubMed] [Google Scholar]
  21. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  22. Sánchez-Sánchez C., Reyes-Montes de Oca A. Experiencia en oído infectado en lactantes y preescolares. Bol Med Hosp Infant Mex. 1986 Feb;43(2):102–105. [PubMed] [Google Scholar]
  23. Taylor M. L., Díaz S., González P. A., Sosa A. C., Toriello C. Relationship between pathogenesis and immune regulation mechanisms in histoplasmosis: a hypothetical approach. Rev Infect Dis. 1984 Nov-Dec;6(6):775–782. doi: 10.1093/clinids/6.6.775. [DOI] [PubMed] [Google Scholar]
  24. Yamamoto H., Nonaka M., Katz D. H. Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies. J Exp Med. 1979 Oct 1;150(4):818–829. doi: 10.1084/jem.150.4.818. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES